{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:13:27Z","timestamp":1783930407962,"version":"3.55.0"},"reference-count":40,"publisher":"Informa UK Limited","issue":"14","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/doi.org\/10.1080\/policies-text-data-mining"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma Inc.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Oncology"],"published-print":{"date-parts":[[2026,6,9]]},"DOI":"10.1080\/14796694.2026.2676559","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T11:32:23Z","timestamp":1782214343000},"page":"1593-1600","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":1,"title":["Enzalutamide in biochemically recurrent prostate cancer: key findings from subsequent analyses of EMBARK and their implications in clinical practice"],"prefix":"10.1080","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8104-6419","authenticated-orcid":false,"given":"Stephen J.","family":"Freedland","sequence":"first","affiliation":[{"name":"Cedars\u2011Sinai Medical Center","place":["Los Angeles, USA"]},{"name":"Durham VA Medical Center","place":["Durham, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"De Giorgi","sequence":"additional","affiliation":[{"name":"University of Salento","place":["Lecce, Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2026,6,23]]},"reference":[{"key":"e_1_3_6_3_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303974"},{"key":"e_1_3_6_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2300251"},{"key":"e_1_3_6_5_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-046588"},{"key":"e_1_3_6_6_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2478786"},{"key":"e_1_3_6_7_1","doi-asserted-by":"publisher","DOI":"10.1080\/14796694.2025.2479331"},{"key":"e_1_3_6_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2510310"},{"key":"e_1_3_6_9_1","doi-asserted-by":"publisher","DOI":"10.1097\/ju0000000000004890"},{"key":"e_1_3_6_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000004879"},{"key":"e_1_3_6_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2023.08.030"},{"key":"e_1_3_6_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.179"},{"key":"e_1_3_6_13_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2025.43.5_suppl.159"},{"key":"e_1_3_6_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2025.116110"},{"key":"e_1_3_6_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.JU.0001009540.33579.43.06"},{"key":"e_1_3_6_16_1","volume-title":"EAU Guidelines. Presented at the EAU Annual Congress","author":"Cornford P","year":"2024","unstructured":"Cornford P, Tilki D, van den Bergh RCN, et al. EAU - EANM - ESTRO - ESUR - ISUP - SIOG guidelines on prostate cancer. 2024. In: EAU Guidelines. Presented at the EAU Annual Congress; Paris; 2024 Apr. ISBN 978\u201394-92671\u201323-3."},{"key":"e_1_3_6_17_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-025-00959-8"},{"key":"e_1_3_6_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2025.103429"},{"key":"e_1_3_6_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2025.02.006"},{"key":"e_1_3_6_20_1","doi-asserted-by":"publisher","DOI":"10.2217\/cer.14.41"},{"key":"e_1_3_6_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41391-023-00711-0"},{"key":"e_1_3_6_22_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003452"},{"key":"e_1_3_6_23_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000003892"},{"key":"e_1_3_6_24_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.121.262821"},{"key":"e_1_3_6_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2019.06.004"},{"key":"e_1_3_6_26_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.52971"},{"key":"e_1_3_6_27_1","unstructured":"National Comprehensive Cancer Network. Referenced with permission from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines\u00ae) for Prostate Cancer V.5.2026. \u00a9 National Comprehensive Cancer Network Inc. 2026. All rights reserved. Accessed May 5 2026. To view the most recent and complete version of the guideline go online to NCCN.org. NCCN makes no warranties of any kind whatsoever regarding their content use or application and disclaims any responsibility for their application or use in any way."},{"key":"e_1_3_6_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2023.102630"},{"key":"e_1_3_6_29_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(24)00730-7"},{"key":"e_1_3_6_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2023.10.012"},{"key":"e_1_3_6_31_1","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17010147"},{"key":"e_1_3_6_32_1","volume-title":"Presented at: Advanced Prostate Cancer Consensus Conference (APCCC)","author":"Fanti S","year":"2024","unstructured":"Fanti S. How to utilize presence or absence of CT findings on a PSMA PET\/CT?. Presented at: Advanced Prostate Cancer Consensus Conference (APCCC); Lugano, Switzerland; 2024 Apr 25\u201327."},{"key":"e_1_3_6_33_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.22.01662"},{"key":"e_1_3_6_34_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2023.41.6_suppl.303"},{"issue":"1","key":"e_1_3_6_35_1","first-page":"110","article-title":"Enzalutamide in men with high-risk biochemically recurrent prostate cancer: rationale and treatment considerations from EMBARK","volume":"213","author":"Shore ND","year":"2025","unstructured":"Shore ND, De Giorgi U, Freedland SJ. Enzalutamide in men with high-risk biochemically recurrent prostate cancer: rationale and treatment considerations from EMBARK. J Urol. 2025;213(1):110\u2013113.","journal-title":"J Urol"},{"key":"e_1_3_6_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2017.08.103"},{"key":"e_1_3_6_37_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.1641"},{"key":"e_1_3_6_38_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euros.2025.01.001"},{"key":"e_1_3_6_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2025.11.015"},{"key":"e_1_3_6_40_1","doi-asserted-by":"publisher","DOI":"10.1177\/11795549241277181"},{"key":"e_1_3_6_41_1","doi-asserted-by":"publisher","DOI":"10.1097\/JU.0000000000002457"},{"key":"e_1_3_6_42_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01157"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2676559","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/full-xml\/10.1080\/14796694.2026.2676559","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14796694.2026.2676559","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T08:02:09Z","timestamp":1783929729000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14796694.2026.2676559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":40,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2026,6,9]]}},"alternative-id":["10.1080\/14796694.2026.2676559"],"URL":"https:\/\/doi.org\/10.1080\/14796694.2026.2676559","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifon20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-06-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-23","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}